Cargando…
Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands
For patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN), chemotherapy can prolong life and alleviate symptoms. However, expected gains may be small, not necessarily outweighing considerable toxicity and high costs. Treatment choice is to a large extent...
Autores principales: | van der Linden, Naomi, Buter, Jan, Pescott, Chris P., Lalisang, Roy I., de Boer, Jan Paul, de Graeff, Alexander, van Herpen, Carla M. L., Baatenburg de Jong, Robert J., Uyl-de Groot, Carin A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733133/ https://www.ncbi.nlm.nih.gov/pubmed/25876000 http://dx.doi.org/10.1007/s00405-015-3495-y |
Ejemplares similares
-
The cost-effectiveness of (18)FDG-PET in selecting patients with suspicion of recurrent laryngeal carcinoma after radiotherapy for direct laryngoscopy
por: van Hooren, Addy C. G., et al.
Publicado: (2008) -
Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures
por: Mes, Steven W., et al.
Publicado: (2020) -
Prevalence of swallowing and speech problems in daily life after chemoradiation for head and neck cancer based on cut-off scores of the patient-reported outcome measures SWAL-QOL and SHI
por: Rinkel, Rico N., et al.
Publicado: (2015) -
Prophylactic exercises among head and neck cancer patients during and after swallowing sparing intensity modulated radiation: adherence and exercise performance levels of a 12-week guided home-based program
por: Cnossen, Ingrid C., et al.
Publicado: (2016) -
Microvessel density in head and neck squamous cell carcinoma
por: Szafarowski, Tomasz, et al.
Publicado: (2018)